Procter & Gamble Health Ltd

  • BSE Code : 500126
  • NSE Symbol : PGHL
  • ISIN : INE199A01012
  • Industry :PHARMACEUTICALS - MULTINATIONAL

up-arrow 5,577.50 -78.50(-1.39%)

Open Price ()

5,628.50

Prev. Close ()

5,656.00

Volume (No’s)

4,243

Market Cap ()

9,258.31

Low Price ()

5,549.00

High Price ()

5,676.50

 

Book Closure

From Date To Date Announcement
16-Nov-2025 17-Nov-2025 Voting results along with report of the scrutinizer for the postal ballot completed on November 16, 2025 Approval of shareholders for appointment of Mr. Shashank Srowthy as an Executive Director of the Company, via postal ballot. Dear Sir, Please find attached revised outcome of the postal ballot results declared on November 17, 2025, as advised by the exchange. (As Per BSE Announcement Dated on:18.11.2025)
05-Nov-2025 NA Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on November 5 2025 Purpose of the meeting has been revised Further to our letter dated September 29, 2025, regarding the Board meeting scheduled on November 5, 2025, this is to inform you regarding revision in the items proposed to be considered by the Board at the said meeting. The agenda for the meeting of the Board of Directors will now include only following item from the items listed under Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: 1. Approval of the Unaudited Financial Results for the quarter ended September 30, 2025. (As per BSE Announcement dated on: 20.10.2025) Outcome of Board Meeting for the quarter ended September 30, 2025 Outcome of Board Meeting held for the quarter ended September 30, 2025 (As Per BSE Announcement Dated on:05.11.2025)
01-Oct-2025 NA Appointment of Mr. Shashank Srowthy as Executive Director and Chief Financial Officer of the Company, effective October 1, 2025 in place of Mr. Lokesh Chandak.
30-Sep-2025 NA Appointment of Mr. Shashank Srowthy as Executive Director and Chief Financial Officer of the Company effective October 1 2025 in place of Mr. Lokesh Chandak. Mr. Lokesh Chandak has stepped down as Chief Financial Officer of the Company as he will be moving onto his new assignment in P&G.
16-Sep-2025 NA Appointment of Mr. Shashank Srowthy as Executive Director and Chief Financial Officer of the Company, effective October 1, 2025 in place of Mr. Lokesh Chandak.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew